HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth

By Yahoo! Finance   |   1 month ago
HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth

Hologic is seeing strong growth in its GYN Surgical portfolio globally, particularly with products like NovaSure for treating abnormal uterine bleeding. With a focus on minimally invasive treatments for fibroids, the company aims to raise awareness and expand its market reach.

Read More

Did you find this insightful?